[1]
“Comparative study of efficacy of topical anthralin (0.5%) and topical calcipotriol (0.005%) in management of chronic plaque psoriasis”, J Pak Assoc Dermatol, vol. 33, no. 3, pp. 827–831, Aug. 2023, doi: 10.66344/jpad.33.3.2023.2195.